Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BE Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113801015B details a palladium-catalyzed carboxylation method using CO2. This report analyzes cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN104672114A details a green synthesis route for Furosemide intermediates offering high purity and reduced environmental impact for reliable supply chains.
Patent CN103319347A details a green electrosynthesis route for 3-methyl-4-nitrobenzoic acid, offering high purity and reduced environmental impact for supply chains.
Patent CN120210835A enables green electrochemical synthesis of benzylic acids. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN101874016A details a scalable mesylate-based route for CNS drug intermediates, offering superior purity and cost-effective manufacturing solutions.
Optimized preparation of Bilastine via stable carboxylic acid intermediates. Avoids ether cleavage impurities. Ideal for reliable API supplier partnerships.
Novel dehydration method for alpha,beta-unsaturated acids using sulfuric acid. High purity, scalable process for pharmaceutical intermediates.
Patent CN104974036A details a DMF-based purification method for Trimesic Acid, offering lower energy consumption and enhanced supply chain reliability for global manufacturers.
Novel aldol condensation route for obeticholic acid intermediate. High yield, scalable process offering cost reduction in API manufacturing and supply chain reliability.
Patent CN101648866B details a low-energy oxidation process for p-tert-butyl benzoic acid, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN114315556A introduces a metal-free oxidation method using D201 resin, offering high purity aromatic acids with simplified downstream processing for reliable supply chains.
Explore the synthesis of a new substituted ureido methyl benzoate compound. This patent offers a scalable route for high-purity pharmaceutical intermediates targeting diabetes.
Novel synthetic route for 3,4-dichloro-2-nitrobenzoic acid via cyanide hydrolysis. High purity, scalable process for API intermediates.
Advanced synthesis of loteprednol etabonate intermediate via 11-alpha-hydroxy-ADD. High purity, cost-effective route for ophthalmic steroid manufacturing.
Novel patent CN105315320A enables scalable Obeticholic Acid production with enhanced purity and reduced operational risks for global supply chains.
Patent CN110950906B reveals a mild silver-catalyzed route for beta-amino phosphoric acid derivatives, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Novel nitration-bromination-deamination route for 2-bromo-3-fluorobenzoic acid. Cost-effective, scalable pharma intermediate manufacturing with high purity.
Patent CN117402055A enables efficient recycling of mother liquor into high-purity m-fluorobenzoic acid. This process offers substantial cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Advanced synthesis of bendamustine key intermediates via patent CN102558069B. Offers superior purity, safety, and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115594573A reveals a copper-catalyzed route for 4-phenoxybenzoic acid. Achieve high purity and cost reduction in API intermediate manufacturing with scalable technology.